An update on tardive dyskinesia: from phenomenology to treatment
about
Tetrabenazine: Spotlight on Drug Review.Tardive dyskinesia: therapeutic options for an increasingly common disorder.Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study.Medication-Induced Tardive Dyskinesia: A Review and Update.Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic.NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases.Tardive dyskinesia occurring in a young woman after withdrawal of an atypical antipsychotic drug.Sensory aspects of movement disorders.Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.High dose pyridoxine for the treatment of tardive dyskinesia: clinical case and review of literature.Thoughts on selected movement disorder terminology and a plea for clarityCrocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanismDeutetrabenazine in Tics Associated with Tourette Syndrome.Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.Dopamine depleters in the treatment of hyperkinetic movement disorders.Valbenazine: First Global Approval.Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia.Clozapine-induced dysphagia with secondary substantial weight loss.Valbenazine for the treatment of tardive dyskinesia.Functional (psychogenic) stereotypies.Amisulpride Reexposure and Tardive Dyskinesia.Valbenazine (Ingrezza): The First FDA-Approved Treatment for Tardive Dyskinesia.Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesiaInterdisciplinary recognizing and managing of drug-induced tardive oromandibular dystonia: two case reports
P2860
Q27692599-C0B8EC6C-EA7C-4501-A77E-634FC456BFF4Q30566749-272C88AA-2EA3-43EB-AE57-B330AC3542D8Q33714619-0AADC329-F886-4535-81FC-2FA1E22BD896Q33802645-6A2F76AF-FDAB-4384-9492-687BF78DDA20Q34447349-43239DFC-CC9F-4BBA-9357-BE842BAF4885Q34492934-6BED2911-F0CD-4E1E-AF04-6ABE7632D391Q34693244-EE44CD2A-D161-46E6-8747-34FDAB1E498CQ36504557-2F488776-24EB-4182-BE2C-FE7F7E721796Q36595746-9AA23C7C-3C91-4772-AAE9-5C36310761C4Q36727004-FE4A4662-F343-42EA-818F-D291144F877DQ36816763-265F517F-1232-470F-AC54-CF897D7B585AQ37408481-1D0FE1C9-32E5-43A5-BBAF-E1078B7968ACQ37416345-E13613D9-1F5E-4D92-ADA4-587F19E39CD5Q37463955-F519D580-9417-42BB-BC8A-1613CBD20891Q37707292-2B8F32C3-DC1A-41B7-A353-E02B15754266Q39000590-BA821C8B-27C7-43F4-BB58-BDA84930C45AQ39348734-35C4B768-CA6E-409A-9563-8B39E7074B19Q41633984-DE9A648F-7094-4FD1-A160-EDA103EB8774Q47225742-55EE07A4-98AC-41F8-92C0-3C13FD5BD6B0Q47280410-724F5A98-1C30-47B9-9690-2A4CF3DF163BQ47670227-0AE7B8F8-4928-4A31-93BC-645D0DA06339Q47850768-534272CF-E444-41FA-855C-9DF2067EF96AQ49490241-3AF2DD7B-F1B4-4767-9C5C-FCB94C2807FEQ55415826-7ED73700-486F-44B8-95C0-C62A26B6651CQ58700947-4E7BC3DE-F756-427C-A260-71D8337B7AD7Q59136959-3A874F26-64FE-486C-9A3C-4F50CC7C00E9
P2860
An update on tardive dyskinesia: from phenomenology to treatment
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An update on tardive dyskinesia: from phenomenology to treatment
@en
An update on tardive dyskinesia: from phenomenology to treatment.
@nl
type
label
An update on tardive dyskinesia: from phenomenology to treatment
@en
An update on tardive dyskinesia: from phenomenology to treatment.
@nl
prefLabel
An update on tardive dyskinesia: from phenomenology to treatment
@en
An update on tardive dyskinesia: from phenomenology to treatment.
@nl
P2860
P356
P1476
An update on tardive dyskinesia: from phenomenology to treatment
@en
P2093
P2860
P356
10.7916/D88P5Z71
P577
2013-07-12T00:00:00Z